S Reza Jafarzadeh1, Benjamin S Thomas2, David K Warren1, Jeff Gill3, Victoria J Fraser1. 1. Department of Medicine, Washington University School of Medicine, St Louis, Missouri. 2. Department of Medicine, Washington University School of Medicine, St Louis, Missouri Department of Medicine, John A. Burns School of Medicine, University of Hawaii, Honolulu. 3. Division of Biostatistics, Division of Public Health Sciences, Washington University School of Medicine, St Louis, Missouri.
Abstract
BACKGROUND: The long-term and cumulative effect of multiple episodes of bacteremia and sepsis across multiple hospitalizations on the development of cardiovascular (CV) events is uncertain. METHODS: We conducted a longitudinal study of 156 380 hospitalizations in 47 009 patients (≥18 years old) who had at least 2 inpatient admissions at an academic tertiary care center in St Louis, Missouri, from 1 January 2008 through 31 December 2012. We used marginal structural models, estimated by inverse probability weighting (IPW) of bacteremia or sepsis and IPW of censoring, to estimate the marginal causal effects of bacteremia and sepsis on developing the first observed incident CV event, including stroke, transient ischemic attack, and myocardial infarction (MI), during the study period. RESULTS: Bacteremia and sepsis occurred during 4923 (3.1%) and 5544 (3.5%) hospitalizations among 3932 (8.4%) and 4474 (9.5%) patients, respectively. CV events occurred in 414 (10.5%) and 538 (12.0%) patients with prior episodes of bacteremia or sepsis, respectively, vs 3087 (7.2%) and 2963 (7.0%) patients without prior episodes of bacteremia or sepsis. The causal odds of experiencing a CV event was 1.52-fold (95% confidence interval [CI], 1.21- to 1.90-fold) and 2.39-fold (95% CI, 1.88- to 3.03-fold) higher in patients with prior instances of bacteremia or sepsis, respectively, compared to those without. Prior instances of septic shock resulted in a 6.91-fold (95% CI, 5.34- to 8.93-fold) increase in the odds of MI. CONCLUSIONS: Prior instances of bacteremia and sepsis substantially increase the 5-year risk of CV events.
BACKGROUND: The long-term and cumulative effect of multiple episodes of bacteremia and sepsis across multiple hospitalizations on the development of cardiovascular (CV) events is uncertain. METHODS: We conducted a longitudinal study of 156 380 hospitalizations in 47 009 patients (≥18 years old) who had at least 2 inpatient admissions at an academic tertiary care center in St Louis, Missouri, from 1 January 2008 through 31 December 2012. We used marginal structural models, estimated by inverse probability weighting (IPW) of bacteremia or sepsis and IPW of censoring, to estimate the marginal causal effects of bacteremia and sepsis on developing the first observed incident CV event, including stroke, transient ischemic attack, and myocardial infarction (MI), during the study period. RESULTS:Bacteremia and sepsis occurred during 4923 (3.1%) and 5544 (3.5%) hospitalizations among 3932 (8.4%) and 4474 (9.5%) patients, respectively. CV events occurred in 414 (10.5%) and 538 (12.0%) patients with prior episodes of bacteremia or sepsis, respectively, vs 3087 (7.2%) and 2963 (7.0%) patients without prior episodes of bacteremia or sepsis. The causal odds of experiencing a CV event was 1.52-fold (95% confidence interval [CI], 1.21- to 1.90-fold) and 2.39-fold (95% CI, 1.88- to 3.03-fold) higher in patients with prior instances of bacteremia or sepsis, respectively, compared to those without. Prior instances of septic shock resulted in a 6.91-fold (95% CI, 5.34- to 8.93-fold) increase in the odds of MI. CONCLUSIONS: Prior instances of bacteremia and sepsis substantially increase the 5-year risk of CV events.
Authors: Vicente F Corrales-Medina; Daniel M Musher; George A Wells; Julio A Chirinos; Li Chen; Michael J Fine Journal: Circulation Date: 2012-01-04 Impact factor: 29.690
Authors: Mitchell S V Elkind; Cara L Carty; Ellen S O'Meara; Thomas Lumley; David Lefkowitz; Richard A Kronmal; W T Longstreth Journal: Stroke Date: 2011-05-05 Impact factor: 7.914
Authors: Kirsi-Maija Kaukonen; Michael Bailey; David Pilcher; D Jamie Cooper; Rinaldo Bellomo Journal: N Engl J Med Date: 2015-03-17 Impact factor: 91.245
Authors: Vicente F Corrales-Medina; Jose Serpa; Adriana M Rueda; Thomas P Giordano; Biykem Bozkurt; Mohammad Madjid; David Tweardy; Daniel M Musher Journal: Medicine (Baltimore) Date: 2009-05 Impact factor: 1.889
Authors: S Reza Jafarzadeh; Benjamin S Thomas; Jonas Marschall; Victoria J Fraser; Jeff Gill; David K Warren Journal: Ann Epidemiol Date: 2015-10-28 Impact factor: 3.797
Authors: Franziska Schramm; Udo Zur Stadt; Martin Zimmermann; Norbert Jorch; Arnulf Pekrun; Arndt Borkhardt; Thomas Imschweiler; Holger Christiansen; Jörg Faber; Irene Schmid; Tobias Feuchtinger; Gerhard Beron; Monique L den Boer; Rob Pieters; Martin A Horstmann; Gritta E Janka-Schaub; Gabriele Escherich Journal: Blood Adv Date: 2019-11-26
Authors: Federico Angriman; Laura C Rosella; Patrick R Lawler; Dennis T Ko; Hannah Wunsch; Damon C Scales Journal: Intensive Care Med Date: 2022-02-10 Impact factor: 41.787
Authors: Leah B Kosyakovsky; Federico Angriman; Emma Katz; Neill K Adhikari; Lucas C Godoy; John C Marshall; Bruno L Ferreyro; Douglas S Lee; Robert S Rosenson; Naveed Sattar; Subodh Verma; Augustin Toma; Marina Englesakis; Barry Burstein; Michael E Farkouh; Margaret Herridge; Dennis T Ko; Damon C Scales; Michael E Detsky; Lior Bibas; Patrick R Lawler Journal: Intensive Care Med Date: 2021-08-09 Impact factor: 17.440
Authors: Henry E Wang; Justin X Moore; John P Donnelly; Emily B Levitan; Monika M Safford Journal: Clin Infect Dis Date: 2017-07-01 Impact factor: 9.079
Authors: David Kain; Amos J Simon; Avraham Greenberg; Danny Ben Zvi; Boris Gilburd; Jacob Schneiderman Journal: PLoS One Date: 2018-10-12 Impact factor: 3.240